# Optimizing Ocular Outcomes: A Dual-armed Study for Periorbital Burn Management

> **NCT06362226** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Virginia Commonwealth University** · enrollment: 10 (estimated)

## Conditions studied

- Periorbital Burns

## Interventions

- **DRUG:** Steroid/Antibiotic (Maxitrol)
- **DRUG:** 5-FU/Kenalog

## Key facts

- **NCT ID:** NCT06362226
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-28
- **Primary completion:** 2026-11
- **Final completion:** 2027-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06362226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06362226, "Optimizing Ocular Outcomes: A Dual-armed Study for Periorbital Burn Management". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06362226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*